As easily accessible measures of Alzheimer’s disease pathology in blood/plasma are a fairly recent scientific development (amyloid, phospho-tau and total-tau), most of the articles included in the analyses did not provide pathological confirmation, and exclusion of these would have compromised the completeness of the review and meta-analysis. This evidence concerns the gene MAPT and Alzheimer disease.